Illumina Inc. Announces Agreement with the Johns Hopkins University.
Illumina Inc. announced an agreement with the Johns Hopkins University School of Medicine, in collaboration with researchers at the National Human Genome Center at Howard University, to utilize the Infinium HumanHap650Y BeadChip for an asthma study of over 2000 African-American and African-Caribbean individuals and their families. The study will be led by Dr. Kathleen Barnes of Johns Hopkins and is supported by a recent grant from the U.S. National Heart, Lung, and Blood Institute (NHLBI) at the U.S. National Institutes of Health. Study subjects involve African-American volunteers from the Baltimore, Maryland-Washington, DC area, and African-Caribbean volunteers and their family members from Barbados.
